Polaryx Therapeutics, Inc. Common Stock (PLYX) NASDAQ
6.43
-0.04(-0.62%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.43
-0.04(-0.62%)
Currency In USD
| Market Cap | 1.66B |
| Enterprise Value | 1.65B |
| P/E Ratio | -33.88 |
| PEG Ratio | 0.54 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 66.69 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -38.13 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.66 |
| Return On Equity | -2.07 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -7.82M |
| Net Income | -8.99M |
| Diluted EPS | -0.19 |
| Total Cash | 5.14M |
| Total Cash/Share | 0.11 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 8.55 |
| Book Value Per Share | 0.1 |
| 52-Week Change | -81.63 |
| 52-Week High | 48.91 |
| 52-Week Low | 2.2 |
| Moving Average 50 Days | 6.41 |
| Moving Average 200 Days | 6.41 |
| Average Volume | 2.22M |
| Shares Outstanding | 47.18M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |